Genetics of Antiviral Defence
Antiviral defence encompasses the innate immune mechanisms that detect and respond to viral infections, including pattern recognition, interferon signalling, and direct viral restriction. Genetic variants in antiviral genes may influence susceptibility to viral illness and Long COVID.
This page is for educational and informational purposes only. Not a diagnostic tool. Always consult a qualified healthcare provider.
What is Antiviral Defence?
When a virus infects a cell, the innate immune system is the first to respond. Pattern recognition receptors including Toll-like receptors (TLRs), RIG-I-like receptors (RLRs), and cGAS-STING detect viral nucleic acids and trigger interferon production. Type I interferons (IFN-alpha and IFN-beta) then induce an antiviral state in surrounding cells, activating hundreds of interferon-stimulated genes (ISGs). Genetic variants in these sensing and signalling pathways — particularly in TLR7, OAS1, IFNAR2, and IRF genes — have been associated with COVID-19 severity and Long COVID susceptibility.
Biological pathways commonly discussed in relation to Antiviral Defence
Research into Antiviral Defence and Innate Antiviral Immunity has highlighted several biological pathways that may be relevant. Genetic variants within these pathways may influence individual susceptibility, symptom severity, or the trajectory of the condition.
Pattern Recognition
TLR7, TLR3, RIG-I, MDA5, and cGAS detect viral RNA or DNA. Variants reducing detection efficiency (e.g. TLR7 loss-of-function) may impair early antiviral responses.
Interferon Signalling
Type I interferon signalling through IFNAR1/2 activates the JAK-STAT pathway, inducing antiviral gene expression. Variants in IFNAR2, TYK2, and STAT1/2 may affect interferon responsiveness.
Viral Restriction
Intrinsic restriction factors such as OAS1, MX1, SAMHD1, and TRIM5 directly inhibit viral replication. Genetic variants affecting their expression or activity may influence viral clearance.
Nk Cell Activity
Natural killer cells eliminate virus-infected cells. Variants in NK cell activating receptors, KIR genes, and NKG2D ligand genes may influence antiviral NK cell responses.
Key genes studied in relation to Antiviral Defence
The following genes have been studied in relation to Antiviral Defence and Innate Antiviral Immunity. These genes span the biological pathways most commonly discussed in this area of research.
35 genes total studied in relation to Antiviral Defence across the ChronicDNA dataset.
Genetic variants commonly discussed
The following genetic variants (SNPs) are found in genes that have been studied in relation to Antiviral Defence. Each variant represents a position in the genome where individuals may carry different alleles.
73 variants total across genes studied in relation to Antiviral Defence.
How personal DNA data may provide educational insights
Consumer DNA files from 23andMe, AncestryDNA, and MyHeritage contain raw SNP data. When you upload your file to ChronicDNA, the analysis engine checks your genotype against a curated panel of 80+ genes selected for their relevance to Long COVID, ME/CFS, and connected biological pathways - some of which may relate to areas such as Antiviral Defence.
This is not a diagnostic service. Genetic variants do not determine whether you have Antiviral Defence, nor do they predict your clinical outcomes. The report is educational - it explains which variants you carry, what the research says about them, and how they fit into the biological pathways most relevant to chronic illness. All results should be discussed with a qualified healthcare provider.
Related conditions and pathways
Antiviral Defence shares biological pathways and genetic associations with the following related conditions and areas of research.
Frequently asked questions
How do genetic variants affect antiviral defence?
Variants in pattern recognition receptors (TLR7, TLR3), interferon signalling genes (IFNAR2, TYK2), and viral restriction factors (OAS1, MX1) may impair the speed or magnitude of the innate antiviral response, potentially influencing infection severity and viral clearance.
Which antiviral genes are most relevant to COVID-19 and Long COVID?
Genome-wide association studies of COVID-19 severity have identified variants in TLR7, OAS1, IFNAR2, TYK2, and LZTFL1 as significant. These suggest that impaired innate antiviral sensing and interferon signalling may contribute to severe COVID-19 and potentially Long COVID susceptibility.
What is the interferon response and why does it matter?
The interferon response is the primary antiviral signalling cascade activated by innate immune sensors. It induces expression of hundreds of antiviral genes across infected and neighbouring cells. Genetic impairment of this pathway has been associated with severe COVID-19 in multiple studies.
Can consumer DNA tests show antiviral immunity variants?
Yes — variants in TLR7, OAS1, and interferon pathway genes are included in many consumer DNA datasets. ChronicDNA analyses these for educational insights into individual antiviral pathway biology.
Explore DNA insights
If you already have DNA data from 23andMe, AncestryDNA, or MyHeritage, upload your raw file to ChronicDNA and receive a personalised educational report covering genes studied in relation to Antiviral Defence and connected biological pathways.
Get Your Personalised DNA ReportInformational and educational only · Not a diagnostic tool · GDPR compliant
35 genes · 73 variants analysed in relation to Antiviral Defence